← Open Payments lookup

THOMAS CHU: Open Payments

NPI 1972825222 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,059 in 80 payments from 14 companies in 2025. Trend: 2023 $1,522 · 2024 $2,034 · 2025 $2,059

Food & beverage: $1,926Education: $133
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP21$571
GENZYME CORPORATION15$252
Regeneron Healthcare Solutions, Inc.3$250
Amgen Inc.14$219
BioCryst US Sales Co., LLC5$146
ARS Pharmaceuticals Operations, Inc.3$131
LEO Pharma Inc.6$123
Takeda Pharmaceuticals U.S.A., Inc.4$108
SANOFI-AVENTIS U.S. LLC1$99
Arcutis Biotherapeutics, Inc.4$76

Products named: DUPIXENT, FASENRA, TEZSPIRE, AIRSUPRA, BREZTRI, NEFFY, ADBRY, ORLADEYO.

Industry payments across NV — which companies pay providers there.